EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study

Yuexin Zhang, Jingyang Dang, Ruoyu Li, Xixue Chen, Xuejun Zhu, Mingyue Wang

Acta Dermato-Venereologica · 2024

DOI: 10.2340/actadv.v104.11917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2024. Verfasst von Yuexin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing,…. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Acquisita, Pemphigoid, Bullous, Autoimmune Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermolysis bullosa acquisita (EBA) rarely develops in childhood. This study retrospectively recruited paediatric patients with EBA (age ≤ 16 years), diagnosed by clinical and histopathological features and results of immunofluorescence, immunoblotting and enzyme-linked immunosorbent assay (ELISA), and reviews their clinical manifestations, histopathology, immunological features, and responses to various treatments. All 7 included patients presented with inflammatory EBA. Among them, 3 had a bullous pemphigoid-like phenotype. Pathologically, in addition to dermal–epidermal blistering, in all patients, the distribution of neutrophils was superficial perivascular or interstitial, or in the dermal papilla. Mixed neutrophils and eosinophils were detected in 2 of the 3 patients with bullous pemphigoid-like phenotypes. In addition to treatment with glucocorticoids, dapsone was administered in 4 patients, while thalidomide and sulfasalazine were administered in 1 patient. All patients responded to the these therapies. Relapse was mainly due to reduction and cessation of glucocorticoids. In conclusion, EBA in childhood may be unique, and thus distinct from its adult counterpart. Specific treatment and follow-up protocols are required for therapy of this rare autoimmune skin disease in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermolysis Bullosa AcquisitaPemphigoid, BullousAutoimmune DiseasesAdultHumansChildAdolescentRetrospective StudiesDapsoneGlucocorticoids

Substanzen

DapsoneGlucocorticoids

Autor:innen und Institutionen

  • Department of Dermatology, Peking University First Hospital, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, B…

Zitieren

APA

Zhang, Y., Dang, J., Li, R., Chen, X., Zhu, X., & Wang, M. (2024). Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v104.11917

Vancouver

Zhang Y, Dang J, Li R, Chen X, Zhu X, Wang M. Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study. Acta Dermato-Venereologica. 2024. doi:10.2340/actadv.v104.11917

BibTeX
@article{Zhang2024,
  author = {Zhang, Yuexin and Dang, Jingyang and Li, Ruoyu and Chen, Xixue and Zhu, Xuejun and Wang, Mingyue},
  title = {Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study},
  journal = {Acta Dermato-Venereologica},
  year = {2024},
  doi = {10.2340/actadv.v104.11917}
}
Kostenlos starten →